Since the establishment of the National Toxicology Program (NTP), there have been gradual changes in strategies to evaluate the overall toxicity of chemicals as well as their carcinogenic potential. The spectrum of toxicologic information sought on selected chemicals has been broadened by the multidisciplinary approach to evaluating chemicals. This paper describes the scientific rationale and experimental processes used by NTP in designing studies. Also, an outline of current NTP protocols are given for prechronic and chronic toxicitv/carcinorenicitv studies.
Introduction
The National Toxicology Program (NTP) was established in November 1978 by the Secretary of the Department of Health and Human Services (DHHS). The primary rationale was to better integrate DHHS activities and resources concerned with determining the toxicologic potential of chemicals and to establish a more effective dialogue between the health research and regulatory agencies, enabling stronger links between the health research and regulatory needs. Four specific goals of NTP continue to broaden the spectrum oftoxicologic information obtained on chemicals selected; increase the number of chemicals evaluated within resource limits; develop and validate a series of assays and protocols appropriate for regulatory needs; and communicate the plans and results to governmental agencies, the medical and scientific communities, and the public (1) .
Since the establishment of the NTP, there have been gradual changes in strategies to evaluate the toxicity and carcinogenic potential of chemicals. The spectrum of toxicologic information sought on selected chemicals has been broadened by the multidisciplinary approach to evaluate chemicals. The expertise in general toxicology, genetics, reproduction, pathology, chemistry, clinical pathology, animal care, immunology, statistics, and biochemical and molecular toxicology each play a major role in identifying toxic and carcinogenic properties ofchemicals. A number of communications representing NTP efforts in meeting its goals have appeared in the literature (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) .
The objectives of this paper are to present an overview of the scientific rationale involved in designing toxicology and carcinogenesis studies and to outline the experimental protocols used by the NTP in conducting these studies. The studies designed by the NTP are planned to provide maximal toxicology information on chemicals selected. Figure 1 diagrams the general sequence of events from chemical selection to toxicological characterization. Once a chemical is identified as an NTP priority chemical, the process of designing studies begins. The methods established and announced widely by the NTP for nominating, selecting, and designing studies give ample opportunity to industry, nominating/regulatory agencies, and the public to influence the final outcome of study designs (1) . This process has resulted in developing studies and protocols that are used to advance the science and for regulatory purposes as well as developing a toxicity data base on chemicals. In 
Toxicological Evaluation Process

General Considerations for Designing Studies
The NTP evaluates a large variety of chemicals for toxicity/carcinogenicity. The chemicals may be used in agriculture, manufacturing and pharmaceutical industries, or they may be food additives or occur as environmental contaminants. Designing studies for such diverse classes of chemicals requires a flexible approach and avoidance of rigid generic protocols. The NTP has adopted core study protocols in terms ofspecies, strains, group size, and number of dose groups, and duration of exposure for prechronic and chronic studies. However, the toxicity end points studied for chemicals evaluated depend on a number offactors such as use patterns ofthe chemical, anticipated biological effects based on structural similarity to known classes of chemicals, and mechanism(s) of toxicity of chemicals in the same general class. Following are some of the major scientific and practical considerations in designing toxicology studies.
Background Information
A thorough knowledge is essential for background information on the chemicals selected for toxicity/carcinogenicity evaluation. To accomplish this the study toxicologist evaluates all information in the literature, interacts with the individual or agency nominator(s), and consults with manufacturer(s) ofthe chemical and representative regulatory agencies and other scientists. This background information generally includes physical and chemical properties of the chemical, production levels, human exposure data, results from previously conducted mutagenicity and short-term tests, metabolism/ pharmacokinetics studies, teratogenicity, and reproductive toxicity studies. Background material also includes known information relative to carcinogenicity, epidemiology, mechanism of toxicity, neurobehavioral toxicity, immunotoxicity, and other target-organ toxicity. Based on the extent and adequacy of this information, strategies are developed for evaluating chemical toxicity/carcinogenicity, and important areas of toxicology needing more work are identified. Significant portions ofthe study design reflect an effort to fill these data gaps when approbriate. Table 1 gives the information on studies designed for 98 chemicals as an example of this effort.
Whenever possible, during the conduct of 90-day toxicity studies and where appropriate, genetic toxicity, metabolism/disposition, hematology, and reproductive/ (17, 18) . Each dose group consists of a minimum of 50 animals per species/sex, which is considered optimum by the International Agency for Research on Cancer (IARC) (19) and most others involved in these studies.
The adequacy ofgroup size for carcinogenicity studies has also been dealt with in the report by the NTP Ad Hoc Panel (20) . Each of the 39 NTP carcinogenicity studies 
Multidisciplinary Approach
Input from several scientific disciplines (e.g., toxicology, chemical disposition, immunotoxicity, pathology, genetic toxicology, laboratory animal management, chemistry, health and safety, statistics, etc.) is incorporated into the study design. The usefulness of toxicology procedures are critically reviewed by the various disciplines before they are incorporated into study designs. The toxicology procedures are continuously improved and validated by the NTP and contract laboratories. Recent publications on the development of a battery of assays for assessing chemical-induced immunotoxicity (15) and measurement of behavior indices of neurotoxicity are some ofthe examples for improvement of procedures (16, 21) .
Experimental Animals
The toxicology and carcinogenesis studies are conducted in rats and mice. Fischer 344 rats and B6C3F1 (C57BL/6N x C3H/HENMTV-) mice are the selected experimental animals for carcinogenesis studies and will continue to be used for NTP prechronic and chronic toxicity/carcinogenicity studies until data show that other strains/species would be more relevant. The historical background on selection ofthese animals has been reviewed by Weisburger (22 Pulmonary system is primary target system of toxicity
Multiple routes Selected to mimic human exposure when more than one route is common Table 4 gives major criteria used for selection of the most frequently used routes of exposure. In addition to the criteria listed in the table, the input from a regulatory agency may play a major role in selecting a route that helps in hazard risk assessment. NTP has begun using microencapsulation of chemicals as an alternative means of incorporating those chemicals into animal feed when they can not be mixed easily or homogeneously in feed because of unpalatability, volatility, or reactivity (25, 26) .
Chemical
In general, the chemicals selected for evaluation of toxicity studies are representative of substances to which the human population is exposed. In most instances the materials used are commercial or technical grades (27, 28) . However, there are some instances when it is not practical to use commercial chemicals, which include the following:
* If the material being evaluated for toxicity is sparingly soluble or not soluble in water or unstable in the dosing mixture, the material can be used in its salt form to increase solubility and possibly stability. * When a number ofstructurally related chemicals are evaluated to establish structure-activity relationships, the purest chemicals available are selected for toxicity/carcinogenicity studies. * If the commercial grade of the material contains a contaminant that could confound the interpretation of the results because of its own toxicity, the pure chemical is used to avoid possible interaction between the components; conversely, if the minor component(s) of a commercial product are suspected of being responsible for the overall toxicity of the product, then that contaminant in pure form may be selected for toxicity evaluation.
Structure-Activity Relationships
One of the NTP criteria for chemical selection is the understanding of structure-activity relationships (SAR). This understanding thereby assists in defining groups of chemicals that should be evaluated toxicologically. The Interagency Testing Committee (ITC) also uses structure-activity as one of the criteria for selecting chemicals. SAR may be used to evaluate the potential hazards of chemicals that have not undergone toxicity evaluation and also help in interpreting toxicity/ carcinogenicity data. Helmes et al. (29) 
Health and Safety Considerations
The design and activities of the health and safety program are carried out to protect the workers handling chemicals under study and to safeguard the environment by complying with regulations and guidelines for disposing of chemicals and residues being studied (30) . It is of the utmost importance that the health and safety aspects of chemicals being evaluated are considered early in the process, preferably at the time of the study designs. In general, adequate methods are available or can be developed to meet health and safety requirements. For inhalation studies where high flammability of materials may be a concern, the maximum concentration used could necessitate extensive safety precautions.
Selection of Dose Levels
The selection of dose levels especially for chronic toxicity/carcinogenicity studies is a topic that requires a separate and extensive review paper. Therefore, a brief description on dose selection is discussed here. For more details, the reader is referred to publications by Huff et al., the NTP, and Haseman (14, 20, 31) .
The selection of dose levels for 90-day studies is generally based on the infonnation from preceding 14-day toxicity studies; however, there may be a number of instances when the dose levels are selected based on the information available in the literature, and no 14-day study is needed. Usually, the 90-day studies have five dose groups and a control group. The highest exposure group selected for studies is predicted to produce frank toxicity, and the lowest dose is expected to produce no adverse effects in the animals. The highest dose should ideally produce no mortality. The lower dose levels are generally spaced logrithmically using a factor of 2 or simply halving the concentrations. It is expected that a gradation of toxic responses will be observed at these dose levels.
The highest dose selected for carcinogenicity studies, also termed the maximum tolerated dose (MTD) , is predicted to produce only minimal yet observable toxicity in the animals. The toxicity end points used in selecting that dose level are listed in Table 5 . Depending on the toxicity end points used for an individual chemical during prechronic toxicity studies, one or several end points in combination may be used to select the highest dose. The selection of dose levels is essentially a professional judgment; it is based on input from various specialities and differs from chemical to chemical. However, the basic philosophy of dose selection for carcinogenicity studies by the NTP remains essentially the same as that described by Sontag et al. (32) . The major change has been in broadening of the toxicology profile by the NTP in its 90-day studies, giving added confidence in estimating the dose levels selected, which according to NCI guidelines "causes no more than a 10% weight decrement as compared to the appropriate control group; and does not produce mortality, clinical signs oftoxicity, or pathologic lesions (other than those that may be related to a neoplastic response) that would be predicted to shorten the animal's natural life span." The histopathologic and body weight changes have been major parameters in estimation of high dose. However, hematology data for nitroaromatics, biochemical parameters for organophosphate pesticides, hormonal levels for chemicals causing thyroid toxicity, clinical signs oftoxicity for central nervous system depressants or stimulants, and behavioral and neurotoxicity parameters for chemicals primarily affecting the nervous system are some of the examples where these endpoints have been major determinants or aided in the selection ofhigh-dose levels for carcinogenicity studies. Instances where criteria other than toxicity parameters are considered in selection of dose levels are listed in Table 6 . 
Protocol Outlines of Prechronic and Chronic Studies
The conduct of prechronic and chronic toxicity/carcinogenicity studies are described in the official NTP Statement of Work document. This large document presents, in considerable detail, the NTP requirements and procedures for performing toxicology studies. These detailed guidelines are essential to the success of doing our studies and, in particular, to be able to compare results across studies done at various laboratories (35) . The following sections give an outline of core protocols for 14-day and 90-day toxicity studies and 24-month chronic toxicity/carcinogenicity studies, along with frequent toxicity end points incorporated into study protocols. All of these studies are performed under Good Laboratory Practices (36).
14-Day Toxicity Studies
The purpose of the 14-day studies is to characterize the toxicity associated with a substance administered to animals for 14 days. The objectives are to identify possible target organ(s), toxic effect similarities, and possible differences in sensitivity between sexes and species and dose-response relationships of toxicity to provide dose selection information for subsequent studies.
The usual protocol (Table 7) for 14-day studies consists of six groups (five dose and one control) of animals of each species and sex with five animals per dose group. The control animals receive the vehicle in which the substance is administered. The animals are observed two times daily, at least 6 hr apart (before 10:00 AM and 2:00 PM), including holidays and weekends, for clinical signs and pharmacologic and toxicologic effects, and moribundity or death. Body weights and organ weights (liver, thymus, right kidney, right testes, heart, brain, and lungs, plus other organs as appropriate) are determined for all animals surviving until the end ofthe study.
A complete necropsy is performed on all exposed and control animals and all tissues are preserved in formalin.
If histopathological examination is required these tissues are trimmed, embedded, sectioned, and stained with hematoxylin and eosin, and evaluated.
90-Day Studies
The objective of 90-day studies is to characterize the toxicity associated with exposure over a period of usually 13 weeks including identification of target organ(s), lesions, similarities and differences in sensitivity between species and sexes, and the slope of doseresponse curve. These studies may be extended up to 6 months if it is considered that the expression of toxic effects will take longer than 90 days or if the available information suggests a carcinogenic effect may be observed (e.g., benzidine dyes), Data from 90-day studies are the primary information source used for selecting dose levels for 2-year studies. The core protocol (Table 8) for 90-day studies generally consists of five dosed groups plus one control group, ten animals/sex/species. The animals are exposed to the chemical for 13 consecutive weeks, after which they are killed without any recovery period. The treatment of animals, regimens for in-life observations, necropsy, and organ weight are the same as for 14-day studies. A complete histopathologic evaluation includes approximately 32 tissues/organs ( At 65 weeks into the study, up to 10 animals/dose/sex/ species are killed and specific toxicologic parameters are determined. Generally, these include specific organ weight, hematology determinations, and complete necropsy and histopathologic evaluation of tissues from all animals in all dose groups plus control groups. Other toxicity end points are incorporated, depending on the chemical being evaluated. Information from these 15-month evaluations allows better planning and more astute pathology examinations; for example, more histopathologic sections can be taken for obvious target organs. Remaining animals that are exposed for 2 years are killed 1 week after cessation of treatment. A complete necropsy and a histopathologic evaluation (Table 9) 
Conclusions
This paper gives a briefoverview ofthe toxicology and long-term carcinogenesis studies designed and conducted by the NTP. The core design in terms of number of dose groups and group sizes for 14-day and 90-day studies are not significantly different from the ones used in the past (32) . The major difference in the prechronic studies perforned in the past involve the primary objective of establishing doses to be used in subsequent carcinogenesis studies. The objectives of 90-day studies are generally 2-fold: to more completely characterize toxicity of the chemicals (stand-alone studies) and to develop data of a wide scope to better design toxicity/ carcinogenicity studies. The objectives of chronic toxicity/carcinogenicity are to evaluate long-term toxicity as well as the carcinogenic potential of chemicals. In addition, chronic studies are conducted to evaluate doseresponse relationships. An interim evaluation, usually at week 65, is included to evaluate long-term and/or late appearing toxic effects of the chemicals in the absence of old age lesions that are normally found at 104 weeks that can mask toxic lesions (37) .
The NTP studies are designed to exploit the uniqueness of the chemical being evaluated; therefore, flexibility is important in the protocol development of each study. To accomplish this, NTP uses a multi-disciplinary team of experts within its organization who review and evaluate the appropriateness of toxicology procedures for each study design. As scientific advances in toxicology are discovered that are directly relevant to these studies, newer techniques will be adopted where appropriate.
